Rocketship India
Crafting the US-India Corridor: Insights from the Disruptors
When & Where
05/03/2023
2:30 pm – 3:00 pm
Hall A3 - SCCC, Santa Clara, CA
About This Talk
Speakers
She is the founder and CEO of INK talks where she curate stories, build multi-disciplinary community, and enable leaders. She also speaks about various aspects of leadership like redefining success, women at work, and the power of storytelling in business. Moreover, she loves to host events --both online and offline-- and to interview achievers to reveal the person behind personality. Prior to INK, she spent over two decades in the US in leading roles in technology (at Intel), venture capital (at Global Catalyst Partners), and launching and shaping initiatives for non-profit organizations (at American India Foundation). I moved back to India (Bengaluru) to disseminate the holistic India story to the rest of the world. She holds MBAs from Portland State University and Bajaj Institute, attended IIT (Indian Institute of Technology) Mumbai, and was gold medalist in undergraduate mathematics at Osmania University, Hyderabad. Having waded through domains like math, venture capital, and technology where women are under-represented, she is an ardent advocate of women at work. She pens a column on the topic for Fortune magazine. She was honored to be listed in Forbes’ ‘Women to Watch in Asia’.
"Karl Mehta is a serial entrepreneur, author, investor, engineer, and civil servant with over 20 years of experience in founding, building, and funding technology companies in the U.S. and international markets. He founded EdCast in 2014, serving as CEO, and joined Cornerstone’s executive leadership team as Managing Director of the EdCast Business Unit after the close of Cornerstone’s acquisition of EdCast. Karl has held several leadership positions in his expansive career, including as former venture partner at Menlo Ventures, a leading VC firm of Silicon, and as the Founder & CEO of PlaySpan Inc., acquired by Visa Inc. (NYSE:V), the world’s largest payment network. Karl also served as a White House Presidential Innovation Fellow, selected by the Obama Administration during the inaugural 2012-13 term. He was recently appointed by Governor Brown to the Workforce Investment Board of the State of California. In 2010, Karl won the “Entrepreneur of the Year” award from Ernst & Young for Northern California. Karl is on the boards of Simpa Networks and on the advisory board of Intel Capital and Chapman University’s Center of Entrepreneurship. Karl is founder of several non-profit’s including Code For India and Grassroots Innovation. He is author of ‘Financial Inclusion at the Bottom of the Pyramid‘."
Dr. Anurag Mairal is an Adjunct Professor of Medicine and the Director, Global Outreach Programs at Stanford Byers Center for Biodesign, Stanford University. He is also a Faculty Fellow and Lead for Technology Innovation and Impact at Center for Innovation in Global Health. In these roles, he leads initiatives focused on applying the biodesign process to resource-constrained settings globally. Further, he facilitates opportunities for students, faculty and fellows at Stanford to work on global healthcare needs. He is founding co-Director for MED 232, Global Health: Scaling Health Technology Innovations in Low Resource Settings, and was part of the founding faculty team for BIOE 371, Global Biodesign: Medical Technology in an International Context, graduate-level courses offered to engineering, business, and medical students at Stanford University. Earlier, he served as Associate Director for the Stanford-India Biodesign and Singapore-Stanford Biodesign programs. He serves as the Founding Chair of BME IDEA APAC, a community of medtech innovation programs in Asia Pacific, partnering closely with the industry and academia in the region. He is also an Honorary Professor at University of Cape Town, South Africa. Concurrently, he is a co-founder and Executive Vice President of Orbees Medical, a SF Bay Area-based strategy consulting firm serving global healthcare industry, with a focus on medtech, pharmaceutical, and digital health industry.